官方APP下载:英语全能特训(微信小程序版,支持苹果手机、安卓手机)
创办于2003年
UNSV记不住?那就记中文谐音“忧安思危”吧!
  Slow and Steady Wins the Race!
UNSV英语学习频道 - Slow and steady wins the race!
公众微信服务号
英语全能特训(微信公众服务号)
UNSV英语学习频道淘宝网店
客服短信:18913948480
客服邮箱:web@unsv.com
初级VIP会员
全站英语学习资料下载。
¥98元/12个月

SCIENCE REPORT - New Cold Drug

阅读次数:


VIP会员专享下载:(非VIP会员无权下载!如果想下载,但还不是VIP会员,请点此订购
下载方式:使用鼠标右键(注意是鼠标右键!)点击下面的MP3音频/MP4视频链接,然后选择“另存为…”。
PDF节目文稿 PDF节目文稿  MP3节目录音 MP3节目录音 
文章正文
同步字幕

This is the VOA Special English Science Report.

American researchers say they have developed the first drug that can effectively treat adults suffering a viral respiratory infection called the common cold.

A cold is an infection of the breathing system. About fifty percent of colds are caused by a group of viruses known as picornaviruses (pa-CORN-a-viruses). These small particles spread from person to person through the air. The virus first infects the tissues in the nose and throat. Signs of a cold include sore throat, discharge of fluids from the nose, sneezing, coughing and difficulty breathing. The sinuses, ears and lungs may also become infected. This can lead to serious conditions like bronchitis or pneumonia.

Medical experts say Americans suffer as many as one-thousand-million colds every year. The experts say colds result in fifty-one-million visits to doctors each year. Yet no treatments are effective against the picornavirus.

Researchers at the ViroPharma company in Exton, Pennsylvania say they have developed such a drug. It is called pleconaril (pla-CON-ah-rill). The researchers say the drug attacks the picornavirus. It interferes with the infection process and prevents the virus from reproducing.

Researchers at the University of Virginia in Charlottesville studied the drug. They reported the results at an infectious disease conference in Chicago, Illinois. They said pleconaril reduces the length and severity of a cold.

One study involved more than two-thousand people with colds who were divided into two groups. One group took four-hundred milligrams of pleconaril three times a day for five days. The other group took an inactive substance. Sixty-five percent of those in the study had a cold caused by a picornavirus.

The people infected with the picornavirus who took pleconaril suffered from the cold for six days. The others who took the inactive substance suffered for seven days. The researchers said the drug made people feel better sooner when the cold was caused by a picornavirus. They also said the drug began to ease the signs of the cold within one day. And it stopped the discharge of nasal fluids one day sooner than usual.

The United States Food and Drug Administration is examining the research on pleconaril. Officials at ViroPharma say they expect the drug to be approved later this year.

This VOA Special English Science Report was written by Nancy Steinbach.

网友的学习评论(0条):
版权所有©2003-2019 南京通享科技有限公司,保留所有权利。未经书面许可,严禁转载本站内容,违者追究法律责任。 互联网经营ICP证:苏B2-20120186
网站备案:苏ICP备05000269号-1中国工业和信息化部网站备案查询
广播台